Centene CEO Michael Neidorff told attendees at the J.P. Morgan Healthcare Conference Monday, “The growth in the exchange has been so dramatic. … We had planned on incremental growth, but not that much.”
The enrollment reflects a growth of at least 400,000 from the third quarter ended Sept. 30, 2017, Evercore ISI analyst Michael Newshel told the publication.
Mr. Newshel also said while Centene’s numbers are likely to raise the insurer’s forecast, taking on so many members in the “volatile” individual market puts Centene at risk where other payers have pulled back.
More articles on payer issues:
UPMC, Highmark to extend in-network access to 10+ hospitals
5 payers in the headlines
Centura Health, Cigna reach contract impasse as deadline looms
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
